[HTML][HTML] Immune responses in mildly versus critically ill COVID-19 patients
H Nasrollahi, AG Talepoor, Z Saleh… - Frontiers in …, 2023 - frontiersin.org
The current coronavirus pandemic (COVID-19), caused by SARS-CoV-2, has had
devastating effects on the global health and economic system. The cellular and molecular …
devastating effects on the global health and economic system. The cellular and molecular …
[HTML][HTML] Epigenetic perspectives associated with COVID-19 infection and related cytokine storm: an updated review
A Dey, K Vaishak, D Deka, AK Radhakrishnan, S Paul… - Infection, 2023 - Springer
Purpose The COVID-19 pandemic caused by the novel Severe Acute Respiratory Syndrome
Corona Virus 2 (SARS-CoV-2) has put the world in a medical crisis for the past three years; …
Corona Virus 2 (SARS-CoV-2) has put the world in a medical crisis for the past three years; …
[HTML][HTML] From Cytokine Storm to Cytokine Breeze: Did Lessons Learned from Immunopathogenesis Improve Immunomodulatory Treatment of Moderate-to-Severe …
G Rondovic, D Djordjevic, I Udovicic, I Stanojevic… - Biomedicines, 2022 - mdpi.com
Complex immune response to infection has been highlighted, more than ever, during the
COVID-19 pandemic. This review explores the immunomodulatory treatment of moderate-to …
COVID-19 pandemic. This review explores the immunomodulatory treatment of moderate-to …
[HTML][HTML] A Retrospective Assessment of Laboratory Findings and Cytokine Markers in Severe SARS-CoV-2 Infection among Patients of Roma Population
A Mocanu, VE Lazureanu, AR Marinescu… - Journal of Clinical …, 2022 - mdpi.com
Growing research data suggests that the severity of COVID-19 is linked with higher levels of
inflammatory mediators, such as cytokines, chemokines, tumor necrosis factor, C-reactive …
inflammatory mediators, such as cytokines, chemokines, tumor necrosis factor, C-reactive …
[HTML][HTML] MicroRNA Let-7 Plays an Important Role in the Immunopathology of COVID-19: A Systematic Review
RL Pessôa, G da Rosa Abreu, RB de Oliveira - Immuno, 2023 - mdpi.com
COVID-19 has presented itself as a challenging task to medical teams and researchers
throughout the world, since the outbreak of SARS-CoV-2 started in the Chinese city of …
throughout the world, since the outbreak of SARS-CoV-2 started in the Chinese city of …
[HTML][HTML] COVID-19 and sulfonylureas: A reminder of the pleiotropic actions of an old class of drugs just before their swansong
T Koufakis, DS Popovic, S Metallidis, K Kotsa - Metabolism, 2022 - ncbi.nlm.nih.gov
Sulfonylureas (SUs) have been used for the treatment of hyperglycemia for more than 60
years and are currently the second most commonly prescribed antidiabetic agents …
years and are currently the second most commonly prescribed antidiabetic agents …
Mesenchymal stromal cells (MSCs) as a therapeutic agent of inflammatory disease and infectious COVID-19 virus: live or dead mesenchymal?
The COVID-19 infection is a worldwide disease that causes numerous immune-inflammatory
disorders, tissue damage, and lung dysfunction. COVID-19 vaccines, including those from …
disorders, tissue damage, and lung dysfunction. COVID-19 vaccines, including those from …
[HTML][HTML] Dissecting Physiopathology of COVID-19
JZ Kubiak, M Kloc - International Journal of Molecular Sciences, 2022 - mdpi.com
The COVID-19 pandemic declared on 11 March 2020 by WHO [1] triggered an astounding
wave of research on all aspects of this novel viral disease. The pace of research in this …
wave of research on all aspects of this novel viral disease. The pace of research in this …
[HTML][HTML] Uncovering the information immunology journals transmitted for COVID-19: A bibliometric and visualization analysis
J Zhao, J Zhu, C Huang, X Zhu, Z Zhu, Q Wu… - Frontiers in …, 2022 - frontiersin.org
Background Since the global epidemic of the coronavirus disease 2019 (COVID-19), a large
number of immunological studies related to COVID-19 have been published in various …
number of immunological studies related to COVID-19 have been published in various …
Multidrug-resistant VAP before and during the COVID-19 pandemic among hospitalized patients in a tertiary private hospital
AAAF Aligui, CLR Abad - Antimicrobial Stewardship & Healthcare …, 2023 - cambridge.org
Background: There is limited data on ventilator-associated pneumonia (VAP) and multidrug-
resistant VAP (MDR VAP) among COVID-19 patients. Methods: A retrospective study in a …
resistant VAP (MDR VAP) among COVID-19 patients. Methods: A retrospective study in a …